X-RAY POWDER DIFFRACTION IN QUALITY CONTROL OF MEDICINES

X-ray powder diffraction is one of the methods used for detection and analysis of polymorphic forms of pharmaceutical substances. The article elucidates the concept of polymorphism, briefly explains physical characteristics of this phenomenon, conditions of polymorphic transformations and the prevalence of polymorphic forms among drug substances. It should be noted that polymorphism is observed in drug substances belonging to different pharmacologic  classes. Polymorphic  forms of the same drug substance have different solubility, melting point,  resistance to oxidation and to other destructive processes, and, consequently, different surface properties which affect both the rate of absorption of the drug substances and their stability as components of dosage forms. This calls for the need to control the quality of drug substances for potential presence of polymorphic forms. The use of diffraction methods for examination of cryomodified forms of various biologically active compounds obtained by evaporation and subsequent precipitation at low temperatures resulted in obtaining polycrystalline substances with new properties. The article provides results of examination of crystalline modifications of phenazepam  in the form of α- and β-polymorphs, tilorone, fabomotizole, zolendronic acid and dehydroepiandrosterone. It was demonstrated that the use of X-ray diffraction analysis for examination and quality control of polymorphic forms of drugs is a necessary component of identification testing.

1. Kuzmin VS, Chernyshev VV, Yashkir VA, Merkulov VA. X-ray powder diffractometry. Practical application in the examination of medicines. Vedomosti Nauchnogo tsentra ekspertizy sredstv meditsinskogo primeneniya = The Bulletin of the Scientific Centre for Expert Evaluation of Medicinal Products. 2015;(2):13–6 (In Russ.)

2. State pharmacopoeia of the Russian Federation. 13th ed. V. 1. Moscow; 2015 (In Russ.)

3. Rudakova IP, Ilyina IG, Skachilova SYa, Melentieva TA, Mikhalev OV, Samylina IA. The polymorphism and properties of drugs. Farmatsiya = Pharmacy. 2009;(8):42–4 (In Russ.)

4. Smirnova IG, Gildeeva GN, Chistyakov VV. Analysis of crystal and three dimensional structures of drug substances. Moscow University Chemistry Bulletin. 2012;67(4):196–201 (In Russ.)

5. Demchenkova EYu, Chistyakov VV. A comparative study of the quality of crystalline substances Verapamile. Biomeditsina = Biomedicine. 2006;(5):22–3 (In Russ.)

6. Gildeeva GN. Polymorphism: influence on the quality of medicines and current methods of analysis. Kachestvennaya klinicheskaya praktika = Qualitative Clinical Practice. 2017;(1):56–60 (In Russ.)

7. Karapetyan AA, Andrianov VG, Struchkov YuT, Bogatskiy AV, Andronati SA, Korotenko TI. Crystal and molecular structure of 7-bromine-5-(o-chlorphenyl)-1,3-dihydro-2H-1,4-benzodiazepine-2-on. Bioorganicheskaya khimiya = Bioorganic Chemistry. 1979;5(11):1684–90 (In Russ.)

8. Zlokazov VB, Chernyshev VV. MRIA — a program for a full profile analysis of powder multiphase neutron-diffraction time-of-flight (direct and Fourier) spectra. J Appl Cryst. 1992;25:447–51. https://doi.org/10.1107/S0021889891013122

9. Chernyshev VV. Structure determination from powder diffraction. Russian Chemical Bulletin. International edition. 2001;50(12):2273–92 https://doi.org/10.1023/A:1015006807065

10. Sergeev GB, Sergeev BM, Morosov YN, Chernyshev VV. β-Polymorph of phenazepam: a powder study. Acta Crystallogr Sect E Struct Rep Online. 2010;66(Pt 10):o2623. https://doi.org/10.1107/S1600536810037402

11. Morozov YuN, Sergeev BM, Kolotilov PN, Shabatin VP, Sergeev GB, Chernyshev VV, et al. Crystalline β-modification of 7-bromine-1,3-dihydro-5-(2-chlorophenyl)-2H-1,4-benzodiazepine-2-it and the method of its production. Patent of Russian Federation, № 2430094; 2011 (In Russ.)

12. Chernyshev VV, Yatsenko AV, Pirogov SV, Nikulenkova TF, Tumanova EV, Lonin IS, et al. Two anhydrous and a trihydrate form of tilorone dihydrochloride: hydrogen-bonding patterns and reversible hydration/dehydration solid-state transformation. Cryst Growth Des. 2012;12(12):6118–25. https://doi.org/10.1021/cg3012475

13. Chernyshev VV, Petkune S, Actins A, Auzins R, Davlyatshin DI, Nosyrev PV, et al. Two polymorphs of afobazole from powder diffraction data. Acta Crystallogr C. 2013;69(Pt 3):299–302. https://doi.org/10.1107/S0108270113004502

14. Chernyshev VV, Shkavrov SS, Paseshnichenko KA, Puryaeva TP, Velikodny YA. Zoledronic acid: monoclinic and triclinic polymorphs from powder diffraction data. Acta Crystallogr C. 2013;69(Pt 3):263–6. https://doi.org/10.1107/S0108270113003089

15. Chernyshev VV, Morozov YN, Bushmarinov IS, Makoed AA, Sergeev GB. New Polymorph of Dehydroepiandrosterone Obtained via Cryomodification. Cryst Growth Des. 2016;16(2):1088–95. https://doi.org/10.1021/acs.cgd.5b01666